Comments on:

Icon to buy division of Cross Country Healthcare

Back to the article » |
Icon PLC plans to buy the clinical trial services division of Cross Country Healthcare Inc. in a deal potentially worth more than $55 million, as the Irish company seeks to grow globally and improve its drug safety consulting. Icon, which is based in Dublin, said Monday it will pay $52 million in cash for the division plus an additional $3.75 million if some performance-based milestones are...

To learn more about commenting on and our community guidelines, please see our comments FAQ.